Zivo Bioscience, Inc.
ZIVO
$17.80
-$0.10-0.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.69M | -13.25M | -7.08M | -7.78M | -8.51M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 4.90K | 224.70K | 439.60K | 439.60K | 434.70K |
| Total Other Non-Cash Items | 8.91M | 7.89M | 255.10K | 257.10K | 1.21M |
| Change in Net Operating Assets | 655.80K | 126.40K | 1.02M | 1.28M | 334.30K |
| Cash from Operations | -4.12M | -5.01M | -5.37M | -5.80M | -6.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 667.60K | 667.60K | 1.67M | 1.76M | 1.61M |
| Total Debt Repaid | -1.69M | -1.72M | -1.75M | -1.76M | -610.80K |
| Issuance of Common Stock | 3.82M | 6.04M | 5.38M | 4.28M | 3.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.80M | 4.99M | 5.30M | 4.28M | 4.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.33M | -18.60K | -69.90K | -1.52M | -1.90M |
